Grant applications are currently open for both our Seed Grant and PNET Pathways Grant programs. Learn more and apply today! The Hirshberg Foundation continues to expand the scope of research and invest in the ideas and scientists who are pushing the field of pancreas research forward. PNET Pathways: https://lnkd.in/gkwacjdV Seed Grant: https://lnkd.in/gvQCkPHP
Hirshberg Foundation for Pancreatic Cancer Research
Research Services
Los Angeles, CA 313 followers
Focused on finding a cure for pancreatic cancer, empowering patients & families, providing patient education and support
About us
The Hirshberg Foundation for Pancreatic Cancer Research is focused on finding a cure for pancreatic cancer, and empowering the patients and families whose lives are touched by this disease. Founded in 1997, the foundation funds groundbreaking scientific research, provides patient education and support, and sustains hope that this cancer will be eradicated once and for all.
- Website
-
http://www.pancreatic.org/
External link for Hirshberg Foundation for Pancreatic Cancer Research
- Industry
- Research Services
- Company size
- 2-10 employees
- Headquarters
- Los Angeles, CA
- Type
- Nonprofit
- Founded
- 1997
- Specialties
- Research, Patient Resources, Financial Aid, and UCUCLA Center for Pancreatic Diseases
Locations
-
Primary
Get directions
2990 S. Sepulveda Blvd., #300C
Los Angeles, CA 90064, US
Employees at Hirshberg Foundation for Pancreatic Cancer Research
Updates
-
We're proud to announce a new research initiative: the PNET Pathway Grant Program, a focused effort to accelerate high-impact research on pancreatic neuroendocrine tumors (PNETs). While PNETs are less common than pancreatic adenocarcinoma, their biology is complex and their clinical course can vary dramatically. This new grant program will support innovative research aimed at expanding treatment options. Together, we are creating new pathways toward better treatments and improved outcomes for all patients facing pancreatic cancer. https://lnkd.in/gZVJECyu
-
We’re proud to announce our 2025 Seed Grant cohort. This year, we are funding more innovative research than ever before. Our eight Seed Grantees and our 3 Catalyst awardees are addressing some of the most urgent challenges in pancreatic cancer: investigating the biology that drives tumor development, advancing potential treatment approaches, and exploring opportunities to prevent cancer in high-risk individuals. Their bold ideas have the potential to fuel real progress. By investing in early-stage concepts through our Seed Grant and Catalyst Grant Programs, we help move promising discoveries toward real-world impact. Thank you for making this work possible!
-
-
-
-
-
+6
-
-
For 20 years, the Hirshberg Foundation’s Seed Grant Program has launched the careers of promising scientists and fueled discoveries that changed how we understand pancreatic cancer. Now, we’re proud to announce the next chapter: the Hirshberg Foundation UCLA Catalyst Grant Program. This new initiative bridges early discovery and clinical application — accelerating progress from the lab bench to the patient bedside. Meet the 2025 Catalyst Grant recipients: 🔹 Dr. Evan Abt – advancing adenosine-targeting immunotherapy 🔹 Dr. Jason Link – defining natural immune responses in long-term PDAC survivors 🔹 Dr. Roger Lo – uncovering mechanisms of resistance to KRAS inhibitors Each project brings us closer to transforming patient outcomes and finding a cure. Learn more → https://lnkd.in/gnVAnhPN #PancreaticCancerResearch #TranslationalScience #UCLA #HirshbergFoundation #BeyondTheSeed #CatalystGrant
-
-
Dr. Rushika M. Perera received a Hirshberg Foundation Seed Grant in 2014. That early support helped launch a bold research journey. Today, she’s a nationally recognized leader in pancreatic cancer biology at University of California, San Francisco. With multiple NIH grants and groundbreaking discoveries, including her recent Nature publication on pancreatic cancer metastasis, Dr. Perera exemplifies the long-term impact of early-stage funding. She now mentors the next generation of scientists while driving progress through her lab and leadership roles. “The Seed Grant gave me the freedom to be bold and follow the science.” --Dr. Rushika Perera Read her update: https://lnkd.in/ggRYj4ZT
-
Federal research funding cuts threaten lifesaving pancreatic cancer breakthroughs 🚨 The National Science Foundation (NSF) has frozen 300 research grants and the The National Institutes of Health has suspended 500 - a devastating blow to the medical research community, including our teams at UCLA. For 20 years, the Hirshberg Foundation’s Seed Grant Program has turned early ideas into clinical trials and new treatments. Without immediate support, discoveries will stall, talented researchers will be sidelined, and hope for patients will be delayed. Our Beyond the Seed: Bridge to Breakthroughs initiative is more critical than ever. Private funding can keep scientists in the lab and progress moving forward. If you believe in advancing science, in keeping top-tier researchers at the bench, and in bringing discoveries to patients faster, please consider making a gift today. Together, we can ensure progress doesn’t stop. https://lnkd.in/gqakGb_w #PancreaticCancer #ResearchFunding #NeverGiveUp #BeyondTheSeed #BridgeToBreakthrough
-
In 2010, Dr. David Gius had just left the National Cancer Institute. The Hirshberg Seed Grant was a critical investment that helped him start his lab and build momentum. Today, Dr. Gius holds several leadership roles at UT Health San Antonio, where he champions mentorship and collaboration. “The Seed Grant was a launching point,” Dr. Gius shared. A Seed Grant does more than fund a project - it invests in a scientist whose work, leadership, and mentorship multiply progress for years to come. That future is only possible with your support. https://lnkd.in/g-SnEadc
-
Congrats to Dr. Ethan Abel & Dr. Katie Gatsos 🎉 This is the promise of our Seed Grant Program: to launch researchers who not only drive discovery, but mentor the next generation of scientists working toward a cure. We are committed to this fight and we will never give up!
It’s been a very hard year to be a cancer researcher (or any kind of scientist). We’ve faced round after round of funding cuts (my lab included) and increasing negative public sentiment fueled by a warped and toxic political/media environment. Still, this July was a great month for my lab, and it’s worth taking stock in what I have and what my team has accomplished. On July 3rd, my first Ph.D. student, Katie Gatsos, successfully defended her Ph.D.! I am so grateful to have had the opportunity to train and work aside such a wonderful, talented, and fearless young scientist. And now today, her thesis work has finally been published in the journal Molecular Cancer, one of the top journals in the cancer research field! It’s a great accomplishment her and the lab, and is also the highest impact publication I have ever published, and the first from my lab. I’m so proud of Katie and grateful to our many collaborators at Roswell Park Comprehensive Cancer Center and Moffitt Cancer Center, as well as our funding sources (the Pancreatic Cancer Action Network, Hirshberg Foundation for Pancreatic Cancer Research, the SAS Founation for Cancer Research, the Roswell Park Alliance Foundation, and NIH/NCI) for making this a reality. You can read our paper here: https://lnkd.in/gYmawZVM
-